Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine eye drops (II) for dry eye disease
ChiCTR2300070695Phase 4Not yet recruiting
- Sponsor
- Xiamen Eye Center of Xiamen University
- Start
- Feb 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in dry eye syndrome (DED), sponsored by Xiamen Eye Center of Xiamen University. Primary endpoint: Incidence of adverse reactions. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2300070695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070695.